Acutaas Chemicals has received approval for capital expenditure plan for a total outlay of upto Rs 212 crore for establishment of greenfield/brownfield manufacturing plant in the state of Gujarat, for new electronic grade chemicals, to be undertaken either by the company or through any of its subsidiary company.
The project targets a production capacity of up to 81,000 metric tonnes per annum for new electronic grade chemicals. The proposed capacity is to be added by the end of FY 2027-28. The Board of Directors of the company at their meeting held on August 22, 2026, inter alia, has considered & approved the same.
Acutaas Chemicals (formally knowns as Ami Organics) is engaged in business of Custom synthesis and manufacturing of Speciality Chemicals having application in Pharmaceuticals API and others.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1909.90 |
| Dr. Reddys Labs. | 1194.50 |
| Cipla | 1435.00 |
| Lupin | 2190.00 |
| Zydus Lifesciences | 1101.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: